Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$190.52 - $236.72 $213,001 - $264,652
1,118 New
1,118 $259,000
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $77,461 - $93,243
348 Added 20.89%
2,014 $521,000
Q3 2023

Oct 11, 2023

BUY
$253.3 - $285.89 $100,813 - $113,784
398 Added 31.39%
1,666 $428,000
Q2 2023

Jul 10, 2023

SELL
$275.25 - $318.06 $21,744 - $25,126
-79 Reduced 5.86%
1,268 $361,000
Q1 2023

Apr 14, 2023

BUY
$256.56 - $292.34 $126,484 - $144,123
493 Added 57.73%
1,347 $374,000
Q4 2022

Jan 31, 2023

SELL
$252.44 - $306.72 $5.06 Million - $6.15 Million
-20,042 Reduced 95.91%
854 $236,000
Q3 2022

Oct 25, 2022

BUY
$194.69 - $268.46 $4.07 Million - $5.61 Million
20,896 New
20,896 $5.58 Million
Q4 2021

Jan 20, 2022

SELL
$223.92 - $287.77 $242,953 - $312,230
-1,085 Closed
0 $0
Q3 2021

Nov 01, 2021

BUY
$282.99 - $369.05 $78,388 - $102,226
277 Added 34.28%
1,085 $307,000
Q2 2021

Jul 21, 2021

SELL
$259.0 - $414.71 $3.29 Million - $5.27 Million
-12,707 Reduced 94.02%
808 $280,000
Q1 2021

Apr 27, 2021

BUY
$242.95 - $284.63 $1.45 Million - $1.69 Million
5,953 Added 78.72%
13,515 $3.78 Million
Q4 2020

Feb 01, 2021

SELL
$236.26 - $355.63 $1.5 Million - $2.26 Million
-6,352 Reduced 45.65%
7,562 $1.85 Million
Q3 2020

Nov 06, 2020

BUY
$264.77 - $305.71 $1.98 Million - $2.29 Million
7,477 Added 116.16%
13,914 $3.95 Million
Q2 2020

Aug 05, 2020

BUY
$258.66 - $342.55 $1.17 Million - $1.55 Million
4,524 Added 236.49%
6,437 $1.72 Million
Q1 2020

May 07, 2020

SELL
$268.85 - $341.04 $11,022 - $13,982
-41 Reduced 2.1%
1,913 $605,000
Q4 2019

Jan 15, 2020

BUY
$220.06 - $304.07 $83,622 - $115,546
380 Added 24.14%
1,954 $580,000
Q3 2019

Nov 05, 2019

SELL
$217.44 - $243.88 $459,015 - $514,830
-2,111 Reduced 57.29%
1,574 $366,000
Q2 2019

Jul 22, 2019

BUY
$219.29 - $241.72 $588,355 - $648,534
2,683 Added 267.76%
3,685 $862,000
Q1 2019

May 14, 2019

BUY
$216.71 - $338.96 $217,143 - $339,637
1,002 New
1,002 $237,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.